MN SF1137

Board of Pharmacy must adopt rules regarding substitution of drugs used to treat epilepsy or seizures if the FDA determines substitution poses a health risk to patients

Rules must align with FDA interchangeability standards for these specific drugs

Any Board-adopted rule on epilepsy/seizure drug substitution supersedes conflicting provisions in Minnesota Statutes section 151.21, subdivision 3

Board must report proposed rules and associated costs to relevant legislative committees if the rule would increase state public health care program expenses before adopting the rule